Skip to main content

Advertisement

Log in

HIV and COPD: impact of risk behaviors and diseases on quality of life

  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

Purpose

Smoking worsens quality of life among HIV-infected individuals, but it remains unclear if this association is related simply to smoking or to chronic obstructive pulmonary disease (COPD), the end-organ disease caused by smoking.

Methods

Using cross-sectional data from the AIDS Linked to the Intravenous Experience study, we determined the independent effects of smoking, HIV and COPD assessed using the Medical Outcome Studies-HIV questionnaire.

Results

Of 973 participants, 287 (29.5%) were HIV infected and 151 (15.5%) had spirometry-defined obstruction. Eight hundred and thirty-four (85.7%) were current smokers with 23.3 mean pack-years history. HIV infection was independently associated with reduced physical and mental health. COPD was associated with a trend toward worse physical health (−1.48 units; 95%CI −3.33 to 0.38; p = 0.12) and was independently associated with worse mental health (−2.43 units; 95%CI −4.22 to −0.64; p < 0.01). After accounting for COPD and other covariates, smoking was not associated with changes in physical or mental health.

Conclusions

The presence of COPD, rather than smoking, is associated with worse quality of life independent of HIV infection. Diagnosis and management of COPD in former or current smokers with or at risk for HIV may further improve quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

ALIVE:

AIDS Linked to the Intravenous Experience

BMI:

Body mass index

CD4:

CD4+ T-helper cells

CI:

confidence interval

COPD:

Chronic obstructive pulmonary disease

FEV1:

Forced expiratory volume in 1 s

FVC:

Forced vital capacity

HAART:

Highly active antiretroviral therapy

HIV:

Human immunodeficiency virus

IDU:

Injection drug user

IQR:

Interquartile range

MOS-HIV:

Medical outcomes studies-human immunodeficiency virus

QOL:

Quality of life

References

  1. Walensky, R. P., Paltiel, A. D., Losina, E., Mercincavage, L. M., Schackman, B. R., Sax, P. E., et al. (2006). The survival benefits of AIDS treatment in the United States. Journal of Infectious Diseases, 194, 11–19.

    Article  PubMed  Google Scholar 

  2. Burgoyne, R. W., & Tan, D. H. (2008). Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): A balancing act. Journal of Antimicrobial Chemotherapy, 61, 469–473.

    Article  CAS  PubMed  Google Scholar 

  3. Liu, C., Ostrow, D., Detels, R., Hu, Z., Johnson, L., Kingsley, L., et al. (2006). Impacts of HIV infection and HAART use on quality of life. Quality of Life Research, 15, 941–949.

    Article  PubMed  Google Scholar 

  4. Hays, R. D., Cunningham, W. E., Sherbourne, C. D., Wilson, I. B., Wu, A. W., Cleary, P. D., et al. (2000). Health-related quality of life in patients with human immunodeficiency virus infection in the United States: Results from the HIV cost and services utilization study. American Journal of Medicine, 108, 714–722.

    Article  CAS  PubMed  Google Scholar 

  5. Lucas, G. M., Mehta, S. H., Atta, M. G., Kirk, G. D., Galai, N., Vlahov, D., et al. (1988). End-stage renal disease, chronic kidney disease in a cohort of African-American HIV-infected, at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS, 2007(21), 2435–2443.

    Google Scholar 

  6. Kirk, G. D., Merlo, C., O’ Driscoll, P., Mehta, S. H., Galai, N., & Vlahov, D. (2007). HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clinical Infectious Diseases, 45, 103–110.

    Article  PubMed  Google Scholar 

  7. Simone, M. J., & Appelbaum, J. (2008). HIV in older adults. Geriatrics, 63, 6–12.

    PubMed  Google Scholar 

  8. Adeyemi, O., Rezai, K., Bahk, M., Badri, S., & Thomas-Gossain, N. (2008). Metabolic syndrome in older HIV-infected patients: data from the CORE50 cohort. AIDS Patient Care STDS, 22, 941–945.

    Article  PubMed  Google Scholar 

  9. Jemal, A., Ward, E., Hao, Y., & Thun, M. (2005). Trends in the leading causes of death in the United States, 1970–2002. JAMA, 294, 1255–1259.

    Article  CAS  PubMed  Google Scholar 

  10. Gomez, F. P., & Rodriguez-Roisin, R. (2002). Global initiative for chronic obstructive lung disease (GOLD) guidelines for chronic obstructive pulmonary disease. Current Opinion in Pulmonary Medicine, 8, 81–86.

    Article  PubMed  Google Scholar 

  11. Jones, P. W. (2007). Activity limitation and quality of life in COPD. COPD, 4, 273–278.

    Article  PubMed  Google Scholar 

  12. Reardon, J. Z., Lareau, S. C., & ZuWallack, R. (2006). Functional status and quality of life in chronic obstructive pulmonary disease. American Journal of Medicine, 119, 32–37.

    Article  PubMed  Google Scholar 

  13. Carone, M., Bertolotti, G., Anchisi, F., Zotti, A. M., Donner, C. F., & Jones, P. W. (1999). Analysis of factors that characterize health impairment in patients with chronic respiratory failure. Quality of life in chronic respiratory failure group. European Respiratory Journal, 13, 1293–1300.

    Article  CAS  PubMed  Google Scholar 

  14. Burns, D. N., Hillman, D., Neaton, J. D., Sherer, R., Mitchell, T., Capps, L., et al. (1996). Cigarette smoking, bacterial pneumonia, and other clinical outcomes in HIV-1 infection. Terry beirn community programs for clinical research on AIDS. Journal of Acquired Immune Deficiency Syndromes Human Retrovirology, 13, 374–383.

    CAS  Google Scholar 

  15. Crothers, K., Butt, A. A., Gibert, C. L., Rodriguez-Barradas, M. C., Crystal, S., & Justice, A. C. (2006). Increased COPD among HIV-positive compared to HIV-negative veterans. Chest, 130, 1326–1333.

    Article  PubMed  Google Scholar 

  16. Diaz, P. T., Clanton, T. L., & Pacht, E. R. (1992). Emphysema-like pulmonary disease associated with human immunodeficiency virus infection. Annals of Internal Medicine, 116, 124–128.

    CAS  PubMed  Google Scholar 

  17. Diaz, P. T., King, M. A., Pacht, E. R., Wewers, M. D., Gadek, J. E., Nagaraja, H. N., et al. (2000). Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Annals of Internal Medicine, 132, 369–372.

    CAS  PubMed  Google Scholar 

  18. Crothers, K., Griffith, T. A., McGinnis, K. A., Rodriguez-Barradas, M. C., Leaf, D. A., Weissman, S., et al. (2005). The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. Journal of General Internal Medicine, 20, 1142–1145.

    Article  PubMed  Google Scholar 

  19. Reynolds, N. R., Neidig, J. L., & Wewers, M. E. (2004). Illness representation and smoking behavior: A focus group study of HIV-positive men. The Journal of the Association of Nurses in AIDS Care, 15, 37–47.

    Article  PubMed  Google Scholar 

  20. Vidrine, D. J., Arduino, R. C., & Gritz, E. R. (2007). The effects of smoking abstinence on symptom burden and quality of life among persons living with HIV/AIDS. AIDS Patient Care STDS, 21, 659–666.

    Article  PubMed  Google Scholar 

  21. Vlahov, D., Anthony, J. C., Munoz, A., Margolick, J., Nelson, K. E., Celentano, D. D., et al. (1991). The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Research Monograph, 109, 75–100.

    CAS  PubMed  Google Scholar 

  22. Marshall, M. M., McCormack, M. C., & Kirk, G. D. (2009). Effect of cigarette smoking on HIV acquisition, progression, and mortality. AIDS Education and Prevention, 21, 28–39.

    Article  PubMed  Google Scholar 

  23. Wu, A. W., Revicki, D. A., Jacobson, D., & Malitz, F. E. (1997). Evidence for reliability, validity and usefulness of the medical outcomes study HIV health survey (MOS-HIV). Quality of Life Research, 6, 481–493.

    Article  CAS  PubMed  Google Scholar 

  24. Revicki, D. A., Sorensen, S., & Wu, A. W. (1998). Reliability and validity of physical and mental health summary scores from the medical outcomes study HIV health survey. Medical Care, 36, 126–137.

    Article  CAS  PubMed  Google Scholar 

  25. Wu, A. W., Hays, R. D., Kelly, S., Malitz, F., & Bozzette, S. A. (1997). Applications of the medical outcomes study health-related quality of life measures in HIV/AIDS. Quality of Life Research, 6, 531–554.

    Article  CAS  PubMed  Google Scholar 

  26. Jacobson, D. L., Wu, A. W., & Feinberg, J. (2003). Health-related quality of life predicts survival, cytomegalovirus disease, and study retention in clinical trial participants with advanced HIV disease. Journal of Clinical Epidemiology, 56, 874–879.

    Article  PubMed  Google Scholar 

  27. Burgess, A., Dayer, M., Catalan, J., Hawkins, D., & Gazzard, B. (1993). The reliability and validity of two HIV-specific health-related quality-of-life measures: A preliminary analysis. AIDS, 7, 1001–1008.

    Article  CAS  PubMed  Google Scholar 

  28. Revicki, D. A., Wu, A. W., & Murray, M. I. (1995). Change in clinical status, health status, and health utility outcomes in HIV-infected patients. Medical Care, 33, AS173–AS182.

    CAS  PubMed  Google Scholar 

  29. Copfer, A. E., Ampel, N. M., Hughes, T. E., Gregor, K. J., Dols, C. L., Coons, S. J., et al. (1996). The use of two measures of health-related quality of life in HIV-infected individuals: a cross-sectional comparison. Quality of Life Research, 5, 281–286.

    Article  CAS  PubMed  Google Scholar 

  30. Wu, A. W., Rubin, H. R., Mathews, W. C., Ware, J. E., Jr., Brysk, L. T., Hardy, W. D., et al. (1991). A health status questionnaire using 30 items from the medical outcomes study. Preliminary validation in persons with early HIV infection. Medical Care, 29, 786–798.

    Article  CAS  PubMed  Google Scholar 

  31. Schag, C. A., Ganz, P. A., Kahn, B., & Petersen, L. (1992). Assessing the needs and quality of life of patients with HIV infection: development of the HIV overview of problems-evaluation system (HOPES). Quality of Life Research, 1, 397–413.

    Article  CAS  PubMed  Google Scholar 

  32. Miller, M. R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., et al. (2005). Standardisation of spirometry. European Respiratory Journal, 26, 319–338.

    Article  CAS  PubMed  Google Scholar 

  33. Hankinson, J. L., Odencrantz, J. R., & Fedan, K. B. (1999). Spirometric reference values from a sample of the general U.S. population. American Journal of Respiratory Critical Care Medicine, 159, 179–187.

    CAS  Google Scholar 

  34. Ruiz Perez, I., Rodriguez Bano, J., Lopez Ruz, M. A., del Arco Jimenez, A., Causse Prados, M., Pasquau Liano, J., et al. (2005). Health-related quality of life of patients with HIV: Impact of sociodemographic, clinical and psychosocial factors. Quality of Life Research, 14, 1301–1310.

    Article  CAS  PubMed  Google Scholar 

  35. Turner, J., Page-Shafer, K., Chin, D. P., Osmond, D., Mossar, M., Markstein, L., et al. (2001). Adverse impact of cigarette smoking on dimensions of health-related quality of life in persons with HIV infection. AIDS Patient Care STDS, 15, 615–624.

    Article  CAS  PubMed  Google Scholar 

  36. Vidrine, D. J. (2009). Cigarette smoking and HIV/AIDS: health implications, smoker characteristics and cessation strategies. AIDS Education and Prevention, 21, 3–13.

    Article  PubMed  Google Scholar 

  37. Badia, X., Podzamczer, D., Casado, A., Lopez-Lavid, C., & Garcia, M. (2000). Evaluating changes in health status in HIV-infected patients: Medical outcomes study-HIV and multidimensional quality of life-HIV quality of life questionnaires. Spanish MOS-HIV and MQOL-HIV validation group. AIDS, 14, 1439–1447.

    Article  CAS  PubMed  Google Scholar 

  38. Delate, T., & Coons, S. J. (2001). The use of 2 health-related quality-of-life measures in a sample of persons infected with human immunodeficiency virus. Clinical Infectious Diseases, 32, E47–E52.

    Article  CAS  PubMed  Google Scholar 

  39. Wu, A. W., Jacobson, D., Grant, D., Scott-Lennox, J. (1997). Quality of life scores predict clinical trial attrition and mortality. Abstracts of 4th Conf on Retroviruses Opportun Infect, 31, 298.

  40. Feldman, J. G., Minkoff, H., Schneider, M. F., Gange, S. J., Cohen, M., Watts, D. H., et al. (2006). Association of cigarette smoking with HIV prognosis among women in the HAART era: A report from the women’s interagency HIV study. American Journal of Public Health, 96, 1060–1065.

    Article  PubMed  Google Scholar 

  41. Pitta, F., Troosters, T., Spruit, M. A., Probst, V. S., Decramer, M., & Gosselink, R. (2005). Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 171, 972–977.

    Article  PubMed  Google Scholar 

  42. Shahriar, J., Delate, T., Hays, R. D., Coons, S. J. (2003). Commentary on using the SF-36 or MOS-HIV in studies of persons with HIV disease. Health Qual Life Outcomes, 1, 25.

    Google Scholar 

  43. Davis, E. A., & Pathak, D. S. (2001). Psychometric evaluation of four HIV disease-specific quality-of-life instruments. Annals of Pharmacotherapy, 35, 546–552.

    Article  CAS  PubMed  Google Scholar 

  44. Oramasionwu, C. U., Brown, C. M., Ryan, L., Lawson, K. A., Hunter, J. M., & Frei, C. R. (2009). HIV/AIDS disparities: the mounting epidemic plaguing US blacks. Journal of the National Medical Association, 101, 1196–1204.

    PubMed  Google Scholar 

  45. Kirkpatrick, P., & Dransfield, M. T. (2009). Racial and sex differences in chronic obstructive pulmonary disease susceptibility, diagnosis, and treatment. Current Opinion in Pulmonary Medicine, 15, 100–104.

    Article  PubMed  Google Scholar 

  46. Des Jarlais, D. C., & Friedman, S. R. (1987). HIV infection among intravenous drug users: epidemiology and risk reduction. AIDS, 1, 67–76.

    CAS  PubMed  Google Scholar 

  47. Overland, E. S., Nolan, A. J., & Hopewell, P. C. (1980). Alteration of pulmonary function in intravenous drug abusers. Prevalence, severity, and characterization of gas exchange abnormalities. American Journal of Medicine, 68, 231–237.

    Article  CAS  PubMed  Google Scholar 

Download references

Financial support

This study was funded in part by grants from the NIH (RO1s HL090483, DA04334 and DA12568). MBD is supported by an Institute for Clinical and Translational Research (KL2) Mentored Career Development Award from the National Institutes of Health.

Conflicts of interest statement

None of the authors of this manuscript have any conflict of interest or financial disclosures related to this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Bradley Drummond.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Drummond, M.B., Kirk, G.D., McCormack, M.C. et al. HIV and COPD: impact of risk behaviors and diseases on quality of life. Qual Life Res 19, 1295–1302 (2010). https://doi.org/10.1007/s11136-010-9701-x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11136-010-9701-x

Keywords

Navigation